Skip to main content
. 2014 Aug 21;99(11):E2162–E2168. doi: 10.1210/jc.2014-2128

Figure 1.

Figure 1.

A, Comparison of endometrial GAB1 mRNA levels over the menstrual cycle in normal women. A significant difference was found among different phases of the menstrual cycle (P = .0004l; ANOVA). Tukey's post hoc test identified that GAB1 mRNA was significantly higher in the proliferative phase compared with the following: 1) early secretory endometrium (P = .04), 2) midsecretory (P = .004), and 3) late secretory endometrium (P = .002). B, Comparison between endometrial GAB1 mRNA expression in endometrium of women with PCOS and normal women (controls). Samples were grouped as proliferative and secretory phases because a distinct difference was found only between the proliferative and secretory phases in normal women. GAB1 mRNA levels were reduced in the proliferative phase of women with PCOS compared with controls (P = .02; ANOVA; Tukey post hoc test). Bar represents mean values. ESE, early secretory endometrium; LSE, late secretory endometrium; MSE, midsecretory endometrium; Prol, proliferative phase.